SE8204585L - Ergopeptinderivat, forfarande for deras framstellning, farmaceutiska beredningar innehallande dessa och deras anvendning vid terapeutisk behandling - Google Patents

Ergopeptinderivat, forfarande for deras framstellning, farmaceutiska beredningar innehallande dessa och deras anvendning vid terapeutisk behandling

Info

Publication number
SE8204585L
SE8204585L SE8204585A SE8204585A SE8204585L SE 8204585 L SE8204585 L SE 8204585L SE 8204585 A SE8204585 A SE 8204585A SE 8204585 A SE8204585 A SE 8204585A SE 8204585 L SE8204585 L SE 8204585L
Authority
SE
Sweden
Prior art keywords
procedures
preparation
pharmaceutical preparations
therapeutic treatment
preparations containing
Prior art date
Application number
SE8204585A
Other languages
English (en)
Other versions
SE452011B (sv
SE8204585D0 (sv
Inventor
H Kobel
J-J Sanglier
H Tscherter
G Bolliger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8204585D0 publication Critical patent/SE8204585D0/sv
Publication of SE8204585L publication Critical patent/SE8204585L/sv
Publication of SE452011B publication Critical patent/SE452011B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
SE8204585A 1981-08-07 1982-08-05 Ergopeptinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dessa derivat SE452011B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH5104/81A CH649300A5 (de) 1981-08-07 1981-08-07 Ergopeptinderivate, ihre herstellung und verwendung.

Publications (3)

Publication Number Publication Date
SE8204585D0 SE8204585D0 (sv) 1982-08-05
SE8204585L true SE8204585L (sv) 1983-02-08
SE452011B SE452011B (sv) 1987-11-09

Family

ID=4287999

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204585A SE452011B (sv) 1981-08-07 1982-08-05 Ergopeptinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dessa derivat

Country Status (27)

Country Link
US (3) US4542135A (sv)
JP (1) JPS5843982A (sv)
AT (1) AT382156B (sv)
AU (1) AU558414B2 (sv)
BE (1) BE894046A (sv)
CA (1) CA1191802A (sv)
CH (1) CH649300A5 (sv)
CS (1) CS235303B2 (sv)
DD (2) DD206379A5 (sv)
DE (1) DE3228230A1 (sv)
DK (1) DK352082A (sv)
ES (2) ES514766A0 (sv)
FI (1) FI72979C (sv)
FR (1) FR2511003B1 (sv)
GB (1) GB2109795B (sv)
GR (1) GR77262B (sv)
HU (2) HU193373B (sv)
IE (1) IE53647B1 (sv)
IL (1) IL66471A (sv)
IT (1) IT1152489B (sv)
MY (1) MY8600311A (sv)
NL (1) NL8203067A (sv)
NZ (1) NZ201504A (sv)
PH (1) PH22998A (sv)
PT (1) PT75384B (sv)
SE (1) SE452011B (sv)
ZA (1) ZA825727B (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
JPS60104129A (ja) * 1983-11-11 1985-06-08 Hitachi Ltd フッ素含有ポリアミド酸誘導体及びポリイミドの製造方法
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
HU193317B (en) * 1985-06-12 1987-09-28 Richter Gedeon Vegyeszet Process for producing 2-bromo-alpha-ergochristin
PT628042E (pt) * 1992-12-24 2002-01-30 Pharmacia & Upjohn Spa Derivados de ergolina serotoninergicos
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
US20070022720A1 (en) * 2005-07-27 2007-02-01 The Toro Company Cleaner for cooling system screen of outdoor power equipment unit
EP2515654A4 (en) * 2009-12-23 2013-04-24 Map Pharmaceuticals Inc NEW ERGOLINANALOGA
EP2723735A4 (en) 2011-06-23 2015-02-18 Map Pharmaceuticals Inc NOVEL ANALOGUES OF FLUORO-ERGOLINE
AU2012355982A1 (en) 2011-12-19 2014-07-10 Map Pharmaceuticals, Inc. Novel iso-ergoline derivatives
US8946420B2 (en) 2011-12-21 2015-02-03 Map Pharmaceuticals, Inc. Neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
CZ304709B6 (cs) * 2013-07-25 2014-09-03 Teva Czech Industries S.R.O. Izolovaný kmen houby Claviceps purpurea (Fr.) Tul., CCM 8404
CN113308442B (zh) * 2021-04-28 2023-06-27 天津大学 重组酿酒酵母菌株及其构建方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314959A (en) * 1961-05-10 1967-04-18 Sandoz Ltd Intermediates for the synthesis of ergot alkaloids
FR2292M (fr) * 1962-06-27 1964-01-27 Sandoz Sa Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine.
CH602765A5 (sv) * 1974-09-27 1978-07-31 Sandoz Ag
CH602766A5 (en) * 1974-09-27 1978-07-31 Sandoz Ag 10-Alpha-methoxy-di:hydro-beta-ergosine derivs.
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
CH626373A5 (sv) * 1977-02-22 1981-11-13 Sandoz Ag
GB1584464A (en) * 1977-04-19 1981-02-11 Farmaceutici Italia Ergot alkaloids
DE2717953A1 (de) * 1977-04-22 1978-10-26 Sandoz Ag Neue therapeutische mischung und verfahren zu deren herstellung
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
CH636011A5 (en) * 1978-01-01 1983-05-13 Sandoz Ag Administration forms for organic compounds
DE2962303D1 (en) * 1978-01-20 1982-04-29 Sandoz Ag Derivatives of ergopeptide alkaloids, process for their preparation and pharmaceutical compositions containing them
DE2803543A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Ergopeptidalkaloidderivate, ihre verwendung und herstellung
YU40046B (en) * 1978-09-04 1985-06-30 Lek Tovarna Farmacevtskih Process for preparing 2-bromo-9,10-dihydroergosine
US4609731A (en) * 1979-10-10 1986-09-02 Sandoz Ltd. Process for brominating ergot alkaloids
DD200571A1 (de) * 1981-07-22 1983-05-18 Alfred Baumert Verfahren zur herstellung von ergopeptinen mit modifiziertem prolinteil
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.

Also Published As

Publication number Publication date
US4681880A (en) 1987-07-21
ES8402348A1 (es) 1984-01-16
GR77262B (sv) 1984-09-11
IT1152489B (it) 1986-12-31
ES8504825A1 (es) 1985-04-16
IT8222768A1 (it) 1984-02-06
DE3228230A1 (de) 1983-02-17
CS235303B2 (en) 1985-05-15
FI822670A0 (fi) 1982-07-30
PT75384B (en) 1985-06-28
MY8600311A (en) 1986-12-31
JPH0437836B2 (sv) 1992-06-22
IE821906L (en) 1983-02-07
AU8678582A (en) 1983-03-03
AU558414B2 (en) 1987-01-29
NL8203067A (nl) 1983-03-01
ES514766A0 (es) 1984-01-16
IE53647B1 (en) 1989-01-04
ZA825727B (en) 1984-03-28
DD211582A5 (de) 1984-07-18
CA1191802A (en) 1985-08-13
DK352082A (da) 1983-02-08
SE452011B (sv) 1987-11-09
GB2109795B (en) 1985-07-03
US4542135A (en) 1985-09-17
CH649300A5 (de) 1985-05-15
ATA302682A (de) 1986-06-15
JPS5843982A (ja) 1983-03-14
IL66471A (en) 1986-02-28
FR2511003B1 (fr) 1986-12-05
FI72979C (sv) 1987-08-10
US4804660A (en) 1989-02-14
DD206379A5 (de) 1984-01-25
AT382156B (de) 1987-01-26
FI822670L (fi) 1983-02-08
IT8222768A0 (it) 1982-08-06
GB2109795A (en) 1983-06-08
NZ201504A (en) 1986-08-08
SE8204585D0 (sv) 1982-08-05
BE894046A (fr) 1983-02-07
ES526119A0 (es) 1985-04-16
HUT37960A (en) 1986-03-28
HU190405B (en) 1986-09-29
PH22998A (en) 1989-02-24
IL66471A0 (en) 1982-12-31
FR2511003A1 (fr) 1983-02-11
HU193373B (en) 1987-09-28
PT75384A (en) 1982-09-01
FI72979B (fi) 1987-04-30

Similar Documents

Publication Publication Date Title
SE8204585D0 (sv) Ergopeptinderivat, forfarande for deras framstellning, farmaceutiska beredningar innehallande dessa och deras anvendning vid terapeutisk behandling
DE3067252D1 (en) Cyclopeptides and pharmaceutical preparations thereof, process for their preparation and their use
DE2861688D1 (en) Quinazoline derivatives, process for their preparation, pharmaceutical preparations and their preparation
NO875299L (no) Insulinpreparat for ikke-paranteral administrasjon.
FR2607813B1 (fr) Alkylamino-8 imidazo (1,2-a) pyrazines et derives, leur preparation et leur application en therapeutique
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
SE8000435L (sv) N-bensylimidazoler med selektivt inhiberande verkan pa tromboxansyntetasenzymet jemte farmaceutiska beredningar innehallande sadana n-bensylimidazoler och sett for deras framstellning
FR2336135A1 (fr) Nouveaux derives de l'ergoline, leur preparation et leur application comme medicaments
FI803849A7 (sv) Nya acylpeptider, farmaceutiska preparat därav, förfarande för deras framställning och deras användnin
NL7804230A (nl) N-alkyl-n-acylderivaten van thienamycine, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten.
DK164669C (da) 2- eller 3-arylsubstituerede imidazooe1,2-aaapyridiner samt fremgangsmaader til fremstilling deraf
FR2605626B1 (fr) Nouveaux derives aromatiques bicycliques, leur procede de preparation et leur utilisation en cosmetique et en medecine humaine et veterinaire
IT8521938A0 (it) Sostanza anti-neoplastica, suoi preparati farmaceutici e relativo metodo di impiego
IT1115596B (it) Metodo per la preparazione di microgranuli gastoresistenti ed enterosolubili di sostanze farmaceutiche,in particolare di sostanze proteiche e microgranuli preparati con detto metodo
FR2593818B1 (fr) Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
FR2605008B1 (fr) Derives d'imidazo (4,5-b)pyridinone-2, leur preparation et leur application en therapeutique
DE2861167D1 (en) 2-amino-thiazoline derivatives, their preparation and their use in pharmaceutical preparations
FR2516509B1 (fr) Derives benzylideniques, leur preparation et leur application en therapeutique
FR2668152B1 (fr) Derives n,o spirocycliques de cyclotriphosphazenes, leur preparation et leur application en therapeutique.
MY114218A (en) The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations.
IT1211944B (it) Derivati azolici,procedimento per la loro produzione,preparati farmaceutici che li contengono,e loro impiego
FR2606409B1 (fr) Derives d'imidazopyridine, leur preparation et leur application en therapeutique
BE850050R (fr) Nouveaux derives de l'ergoline, leur preparation et leur application comme medicaments
DK457486A (da) Bicycliske catechol-derivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende saadanne derivater
FI873483A7 (sv) Oxiranpseudooligosackarider, förfarande för deras framställning, deras användning och farmaceutiska preparat.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8204585-7

Effective date: 19910315

Format of ref document f/p: F